For generations, the genetic data shaping disease prediction has been drawn almost exclusively from people of European descent, quietly encoding inequality into the very tools meant to protect human health. Researchers at Johns Hopkins and the National Cancer Institute have now introduced CT-SLEB, an algorithm that blends machine learning with Bayesian modeling to improve genetic risk scoring across African, Latino, East Asian, and South Asian populations. Published in Nature Genetics in September 2023, the work is both a meaningful advance and a candid admission: better methods can narrow the
News-Medical.net
· Sep 26, 2023
· health
· 3 min de lectura
High
Verificación: Verificado
Johns Hopkins team develops algorithm to improve genetic risk scoring across diverse populations
◉
Health & Medicine
8252 artículos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% coincidencia
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% coincidencia
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% coincidencia
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% coincidencia
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% coincidencia
Cobertura Relacionada
World Socialist Web Site · Aug 22
H5N1 avian flu spreads across Australia with 290 confirmed infections
Australia faces a rapidly spreading H5N1 avian flu outbreak with 290 confirmed infections across all states, threatening…
Devdiscourse · Aug 22 Congo's Bundibugyo Crisis: Health Attacks Threaten Economic Stability Beyond Medical ResponseWHO warns that violence and attacks on health facilities in eastern DRC's Bundibugyo outbreak threaten disease control a…
The Times of India · Aug 22 Reactor blast at Telangana pharma unit kills 2, injures 9A reactor blast at a pharmaceutical unit in Telangana's Yadadri Bhuvanagiri district killed two workers and injured nine…
Google News · Aug 22 Exercise-mimicking weight-loss pill clears first human trialsEnveda's ENV-308, a novel obesity drug designed to replicate exercise's biochemical effects, has successfully completed …
Sesgo y Encuadre
⚖
Article presents scientific research on algorithmic bias reduction with balanced framing, acknowledging both progress and limitations in addressing health disparities.
Bias Direction
center
Confidence
MED
Problem-solution framing with acknowledgment of systemic limitations. The article frames genetic risk-scoring disparities as a solvable technical problem while noting that algorithmic improvements alone are insufficient.
holds promise for reducing health care disparities
historically biased toward European ancestry data
performance gap
Perspectives from affected communities (African, Latino, East Asian, South Asian populations) on the research
Ethical concerns about genetic data collection and privacy in diverse populations
Implementation challenges or barriers to adoption in clinical settings
Counterarguments or skepticism about the algorithm's real-world effectiveness
Discussion of data equity and who benefits from this research
Impacto Geopolítico
🌎
Johns Hopkins develops AI algorithm improving genetic risk prediction across diverse populations, addressing health equity gaps in disease prevention models historically biased toward European ancestry data.
Escalation Risk
low
Confidence
HIGH
Global
Sub-Saharan Africa
Latin America
East Asia
South Asia
United States
Shifts scientific authority from Western-centric genetic research to more inclusive, globally representative data models. Enhances soft power of US research institutions in global health governance. Reduces knowledge asymmetry between developed and developing nations in precision medicine, potentially democratizing access to advanced health technologies.
Similar to the shift from Western-only clinical trials to inclusive global health research standards post-2000s, addressing historical inequities in medical knowledge production and access.
Lente Económico
📈
Johns Hopkins develops CT-SLEB algorithm improving genetic risk-scoring accuracy across diverse populations, addressing healthcare disparities and reducing bias in disease prediction models historically skewed toward European ancestry data.
Market Signal
bullish
Confidence
HIGH
Healthcare and Medical Services
Biotechnology and Genetic Research
Pharmaceutical Industry
Health Insurance
Preventive Medicine
Consumers from non-European ancestry populations gain improved access to accurate genetic risk assessments for major diseases (coronary artery disease, depression, cancers), enabling earlier preventive interventions and more personalized healthcare. This reduces health disparities and improves health outcomes across diverse demographic groups.
Potential regulatory emphasis on algorithm validation across diverse populations; increased funding for genetic studies in underrepresented populations; healthcare policy reforms requiring equity assessments in AI-driven diagnostic tools; possible insurance coverage adjustments based on improved risk stratification; research funding priorities shifting toward inclusive genomic datasets.